[ad_1]
Some senior officials in the Biden administration knew two weeks ago that there were issues with a Johnson & Johnson contractor – issues that could cause a substantial amount of doses of the drug to be delayed, according to a report. vaccine.
Workers at the Emergent BioSolutions plant in Baltimore mixed ingredients from Johnson & Johnson’s single-dose vaccine with ingredients from another vaccine, ruining 15 million doses, it was reported Wednesday.
Future vaccine shipments have since been halted.
But two senior officials working on the COVID-19 response said the problems at the Emerging production plant became evident earlier this month, Politico reported.
And a third official told the outlet that the Department of Health and Human Services discovered Emerging’s blunder last week.
“It was no secret that Emergent did not have a bench of experts in pharmaceutical manufacturing,” said the official.
The company’s failure will delay future shipments of the Johnson & Johnson vaccine, and the distribution of doses to states will be slowed down in the coming weeks, two officials told Politico.
But Johnson & Johnson will still be able to meet the targets set out in its contract with the federal government, an official said.
Johnson & Johnson has pledged to send the government 100 million doses by the end of May, but barely met its target of delivering 20 million doses by the end of March.
The Food and Drug Administration is probing the confusion.
[ad_2]
Source link